IHM
OMED

Iguana Healthcare Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Iguana Healthcare Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,000
Closed -$572K – 97
2016
Q3 		$572K Buy
+50,000
New +$582K 0.1% 79

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Iguana Healthcare Management's OMED Position: Q1 2018 in Review

Iguana Healthcare Management held its OncoMed Pharmaceuticals, Inc. (OMED) position steady in Q1 2018 at 150,000 shares worth $477K. The position accounts for 0.31% of the portfolio, ranked #59.

Iguana Healthcare Management first reported a position in OMED in Q2 2015 and has held it in 12 quarters since. The position peaked at $16.6M in Q3 2016. 66 funds tracked by Wall St. Rank hold OMED as of Q1 2018.

  • Iguana Healthcare Management held 150,000 shares of OncoMed Pharmaceuticals, Inc. worth $477K as of Q1 2018.
  • Iguana Healthcare Management left its OncoMed Pharmaceuticals, Inc. share count unchanged in Q1 2018.
  • OncoMed Pharmaceuticals, Inc. made up 0.31% of Iguana Healthcare Management's portfolio in Q1 2018, its #59 holding.
  • Iguana Healthcare Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and has held it in 12 quarters since.
  • Iguana Healthcare Management's OncoMed Pharmaceuticals, Inc. position peaked at $16.6M in Q3 2016.
  • 66 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.